receptos inc (RCPT:NASDAQ GM)

Executive Profile*

Background*

Dr. Christine A. White, MD co-founded Receptos Inc. (formerly, Apoptos Inc.) in 2007 and serves as its Managing Director. Dr. White serves as a Consultant to the biotech industry. Dr. White served as Senior Vice President of Global Medical Affairs of Biogen Idec. Inc. until 2005. She was with Biogen Idec from 1996 to 2005, where she played a key role in the clinical development, regulatory affairs and commercialization of both Rituxan(R) and Zevalin(R). She joined IDEC ... Pharmaceuticals in June 1996 and served as its Senior Director, Oncology and Hematology Clinical Development until June 2000. She served as Vice President, Oncology and Hematology Clinical Development of IDEC Pharmaceuticals since June 2000. Since May 2001, she served as Vice President, Medical Affairs of IDEC Pharmaceuticals. She served as Chairman of the Board and Member of the California Breast Cancer Research Program's Advisory Council. She served as Director of Clinical Oncology Research of Sidney Kimmel Cancer Center in San Diego, California from 1994 to June 1996 and from 1984 to 1994, she held various positions in the Department of Medicine at Scripps Memorial Hospitals in San Diego, where she served as Medical Director of Oncology Research from 1990 to 1994 and served as Chairman of the Department of Medicine since 1994. She served as Director of Monogram Biosciences, Inc. from August 2008 to August 4, 2009. Dr. White has been a Director of Genoptix, Inc. since January 2009. She has been a Director of Receptos Inc. since 2007 and also serves as its Member of the Scientific Advisory Board. She serves on the scientific advisory board for Patrys Inc. Dr. White has been a Lead Director of MEI Pharma, Inc. since March 26, 2013. Dr. White has been an Independent Director of Arena Pharmaceuticals, Inc. since August 14, 2006 and MEI Pharma, Inc. (alternate name: Marshall Edwards Inc.) since August 10, 2010. She served as a Director of Pharmacyclics Inc. from August 9, 2006 to September 11, 2008. She serves on several editorial boards, including Cancer Biotherapy and Radiopharmaceutical, Expert Review of Anti-cancer Therapy and Journal of Immunotherapy. She is a Member of numerous professional organizations, including the American Society of Clinical Oncology, the American Society of Hematology and the International Society for Biological Therapy of Cancer. She has authored or co-authored more than 100 articles. Dr. White holds a BA degree in Biology and M.D. Degree, both from the University of Chicago and is Board certified in both Internal Medicine and Medical Oncology. She completed Hematology and Oncology fellowship at UCSD and the Salk Institute.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
RCPT:US	$14.22 USD	-0.18

COMPETITOR COMPENSATION